Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole versus placebo prophylaxis for lung infiltrates during induction chemotherapy for acute myeloid leukemia
ISRCTN64013427Phase 3Terminated
- Sponsor
- University Hospital Cologne
- Start
- Nov 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute myeloid leukemia (AML) comparing Voriconazole prophylaxis with Placebo (2 arms). Primary endpoint: Incidence of lung infiltrates. Started Nov 2004; status: terminated.
02
Drugs
voriconazole
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on ISRCTN64013427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN64013427.